The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812529 | PMC |
| http://dx.doi.org/10.1093/femsle/fnv225 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phage therapy: A primer for orthopaedic trauma surgeons.
Injury
November 2024
AO Research Institute Davos, Davos, Switzerland.
Phage therapy (PT) continues to attract interest in the fight against fracture-related infection (FRI), particularly for recurring infections that have not been resolved using conventional therapeutic approaches. The journey PT has taken from early clinical application in the pre-antibiotic era to its recent reintroduction to western clinical practice has been accelerated by the increased prevalence of multi-drug resistant (MDR) pathogens in the clinic. This review will present PT's potential as a precise, adaptable, and effective treatment modality, with a focus on patient and phage selection, as well as the various administration protocols currently applied to patients.
View Article and Find Full Text PDFPhage therapy: an alternative treatment modality for MDR bacterial infections.
Infect Dis (Lond)
October 2024
Department of Microbiology, ICMR-National Institute for Research in Environmental Health, Bhopal, Madhya Pradesh, India.
Article Synopsis
- Many bacteria are becoming resistant to antibiotics, which is a big problem for health care and could make it harder to treat infections.
- The World Health Organization wants to find new types of medicines, like phage therapy, to help fight these strong bacteria that are causing a lot of hospital infections.
- Phage therapy uses special viruses (phages) that attack bacteria, and researchers are working hard to make sure this treatment is safe and effective for patients.
Activity of Bacteriophage D29 Loaded on Nanoliposomes against Macrophages Infected with .
Diseases
October 2023
Tuberculosis Research Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.
The search for new antimicrobial agents is a continuous struggle, mainly because more and more cases of resistant strains are being reported. (MTB) is the main microorganism responsible for millions of deaths worldwide. The development of new antimicrobial agents is generally aimed at finding strong interactions with one or more bacterial receptors.
View Article and Find Full Text PDFReviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria.
BMC Infect Dis
October 2023
African Centre of Excellence in Bioinformatics and Data-Intensive Sciences, the Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O Box 22418, Kampala, Uganda.
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches to treat multi-drug-resistant bacterial infections.
View Article and Find Full Text PDFStructure, Biology, and Applications of Filamentous Bacteriophages.
Cold Spring Harb Protoc
August 2024
School of Natural Sciences, Massey University, Auckland 0632, New Zealand.
The closely related Ff filamentous phages (f1, fd, and M13) have taken a fantastic journey over the past 60 years, from the urban sewerage from which they were first isolated, to their use in high-end technologies in multiple fields. Their relatively small genome size, high titers, and the virions that tolerate fusion proteins make the Ffs an ideal system for phage display. Folding of the fusions in the oxidizing environment of the periplasm makes the Ff phages a platform that allows display of eukaryotic surface and secreted proteins, including antibodies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!